跳至主要内容
临床试验/NCT05416411
NCT05416411招募中不适用

Preoperative RESpiratory Training and MOBilization to Prevent Postoperative Pulmonary Complications in Patients Undergoing Thoracic Surgery (RESMOB): A Multi-center Randomized Controlled Trial

Istanbul University3 个研究点 分布在 1 个国家目标入组 436 人开始时间: 2022年7月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
436
试验地点
3
主要终点
The incidence of postoperative pulmonary complications

研究概览

简要总结

Postoperative pulmonary complications (PPCs) are the most frequent complications occurring in patients undergoing thoracic surgery and they are associated with prolonged hospital stay, decreased survival and expanding medical costs. Implementation of structured and supervised exercise programs including endurance training (ET), respiratory muscle training (RMT) or a combination of both, within the short waiting period before surgery, has been shown to enhance patients' physical fitness, to provide protective effects against PPCs and therefore to spare health care resources by shortening intensive care unit (ICU) and hospital lengths of stay. More recently, a simple intervention consisting in patient's instruction and education about modifiable risk factors, optimal breathing pattern and the impact of physical exercise has emerged as a simple alternative intervention prevent PPCs, although the evidence is inconclusive.

Therefore, the investigators propose a multicentre randomized, open, blinded end point controlled trial testing the hypothesis that preoperative education and instruction focused on breathing exercise and endurance training reduce the occurrence of PPCs in patients undergoing thoracic or abdominal surgery.

Patients with Intermediate-to-high risks factors for PPCs will be randomized on a 1:1 basis into an intervention arm and a usual care arm (Control group). In the Education group, patients will be asked to use a flow resistive device (One set of 30 repetitions, two times a day and to increase their daily physical activities (> 5'000 steps or equivalent) until surgery. Primary study endpoint will be the incidence of PPCs (e.g., atelectasis, pneumonia, respiratory failure) according to the European Perioperative Clinical Outcome definitions. Secondary outcomes will include non-respiratory complications, utilization of hospital resources (e.g., hospital length of stay, ICU admission),and preoperative changes in maximal inspiratory pressure [MIP]. Assuming a rate of 39% PPCs in the controls and a possible reduction to 26% in the intervention group, enrollment of 203 patients per group will provide 80% power with an alpha value of 0.05. Taking into account dropouts (5%) and in-hospital mortality rate (2%), a total of 436 surgical patients will be enrolled.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (> 18 years)
  • Risk factors for PPCs (ARISCAT score >27)
  • Elective intra-abdominal surgery or intrathoracic surgery via an open or minimally-invasive approach, expected to last > 120 min.

排除标准

  • Patients unable to understand the instructions and/or to perform the proposed training program (i.e., poor comprehension, chest pain)
  • COPD GOLD Grade III and IV, lung fibrosis, documented bullae, severe emphysema, pneumothorax
  • Patient with chest pain or at risk of pneumothorax
  • Previous lung surgery
  • Bilateral lung procedures
  • Emergent surgery or organ transplant
  • Planned mechanical ventilation after surgery
  • Uncontrolled asthma
  • Coronary heart disease with angina grade 3 or 4 Canadian Cardiovascular Society
  • documented pulmonary arterial hypertension >25mmHg mean pulmonary arterial pressure (PAP) at rest or > 40 mmHg systolic PAP (estimated by ultrasound)
  • Documented or suspected neuromuscular disease (thymoma, myasthenia, myopathies, muscular dystrophies, others)
  • Intracranial injury or tumor
  • Persistent hemodynamnic instability, intractable shock
  • Pregnancy (excluded by anamnesis and/or laboratory analysis)
  • Enrollment in another interventional study or refusal of informed consent
  • Presence of one of the adverse events, listed as PPCs (aspiration, respiratory failure, pneumonia, atelectasis, cardiopulmonary edema, pleural effusion, pneumothorax)
  • Pleural surgery only, sympathectomy surgery only, chest wall surgery only, mediastinal surgery only, lung transplantation

结局指标

主要结局

The incidence of postoperative pulmonary complications

时间窗: Up to postoperative 5 days

Postoperative pulmonary complications will be investigated during the postoperative 5 days. These complications are named according to the European Perioperative Clinical Outcome (EPCO) definitions (Respiratory failure, aspiration pneumonitis, pneumonia, ARDS, pneumothorax, atelectasis, bronchospasm)

次要结局

  • Length of stay in hospital(Up to 15 days)
  • Preoperative MIP change(7 days)
  • Visual Analog Scale thoracic coughing pain(Up to 5 days)
  • Visual Analog Scale dyspnea(Up to 5 days)
  • Visual Analog Scale thoracic rest pain(Up to 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emre Sertaç Bingül

Medical Doctor, Lecturer

Istanbul University

研究点 (3)

Loading locations...

相似试验